EuroIntervention PCRonline - Connecting with the community

Serban Puricel

6 articles

Mid-term clinical outcomes with everolimus-eluting bioresorbable scaffolds versus everolimus-eluting metallic stents for percutaneous coronary interventions: a meta-analysis of randomized trials

EuroIntervention 2017; just accepted article published in July 2017

Biolimus-eluting versus everolimus-eluting stents in coronary artery disease: a pooled analysis from the NEXT (NOBORI biolimus-eluting versus XIENCE/PROMUS everolimus-eluting stent) and COMPARE II (Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent) randomised trials

EuroIntervention 2017;12:1970-1977 published online November 2016

Published in Volume 12 Number 16, March 2017

Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with coronary artery disease: three-year follow-up of the COMPARE II (Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent) trial

EuroIntervention 2015;11:272-279

Published in Volume 11 Number 3, July 2015

A propensity score-matched comparison between Cardia and Amplatzer PFO closure devices - insights from the SOLUTION registry (Swiss percutaneOus patent foramen ovale cLosUre in recurrent clinical events prevenTION)

EuroIntervention 2015;11:230-237 published online ahead of print May 2014

Published in Volume 11 Number 2, June 2015

Long-term comparison of everolimus-eluting and biolimus-eluting stents

EuroIntervention 2013;9:336-344 published online ahead of print March 2013

Published in Volume 9 Number 3, July 2013

Clinical outcomes after PCI for acute coronary syndrome in unprotected left main coronary artery disease: insights from the Swiss Acute Left Main Coronary Vessel Percutaneous Management (SALVage) study

EuroIntervention 2011;7:697-704

Published in Volume 7 Number 6, October 2011